FDA approves a diabetes drug that also helps protect the heart.

The U.S. Food and Drug Administration (FDA) has approved a prescription medicine called dapagliflozin for adults with type 2 diabetes. This drug works to lower blood sugar levels. It has also been approved for a second, important use: to reduce the chance of being hospitalized for heart failure in people who already have heart disease or have several risk factors for it. This means doctors now have a single medication option that can address both blood sugar management and certain heart-related risks for their patients. The approval is specifically for adults with type 2 diabetes. It is not for people with type 1 diabetes. The drug's effectiveness for blood sugar control is also limited for patients with more advanced kidney disease. As with any new treatment option, this approval provides doctors with another tool to consider for their patients' overall care. It is important to remember that every person's health situation is unique. The most important step for anyone interested in this news is to have an open conversation with their own doctor about what treatments are right for them.